Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial Submitted by admin on Thu, 04/14/2016 - 09:41 Read more about Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial Source Yahoo Headline Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and… News Tags Merck Zepatier elbasvir/grazoprevir hepatitis C
3 Things You Absolutely Must Know About Merck Submitted by admin on Tue, 01/12/2016 - 14:30 Read more about 3 Things You Absolutely Must Know About Merck Source Motley Fool Headline 3 Things You Absolutely Must Know About Merck News Tags Merck M&A Keytruda elbasvir/grazoprevir Kenneth Frazier
3 Potential Blockbuster Drugs Launching in 2016 Submitted by admin on Wed, 01/06/2016 - 10:57 Read more about 3 Potential Blockbuster Drugs Launching in 2016 Source Investors.com Headline 3 Potential Blockbuster Drugs Launching in 2016 News Tags Merck hepatitis C elbasvir/grazoprevir Gilead Sciences sofosbuvir/velpatasvir Eli Lilly psoriasis ixekizumab
Merck’s Share Price Has Been Volatile on Impending Drug Approvals Submitted by admin on Fri, 12/18/2015 - 12:31 Read more about Merck’s Share Price Has Been Volatile on Impending Drug Approvals Source Yahoo/Market Realist Headline Merck’s Share Price Has Been Volatile on Impending Drug Approvals News Tags Merck elbasvir/grazoprevir hepatitis C
Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Hepatitis C Submitted by admin on Sun, 11/15/2015 - 11:39 Read more about Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Hepatitis C Source Yahoo Headline Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinica… News Tags Merck clinical trials elbasvir/grazoprevir hepatitis C
Merck HCV Treatment: The Next Big Breakthrough? Submitted by admin on Wed, 10/21/2015 - 10:31 Read more about Merck HCV Treatment: The Next Big Breakthrough? Source Bidness, ETC Headline Merck HCV Treatment: The Next Big Breakthrough? News Tags Merck hepatitis C elbasvir/grazoprevir MK-36822 MK-84083